Nuclear Medicine and Radiopharmaceutic Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4144630
- 93 Pages
- December 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Nuclear Medicine and Radiopharmaceutic market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Nuclear Medicine and Radiopharmaceutic market segmented into
Diagnostic Radioisotopes
Therapeutic Radioisotopes
Based on the end-use, the global Nuclear Medicine and Radiopharmaceutic market classified into
Oncology
Cardiology
Others
Based on geography, the global Nuclear Medicine and Radiopharmaceutic market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Company
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL NUCLEAR MEDICINE AND RADIOPHARMACEUTIC INDUSTRY
2.1 Summary about Nuclear Medicine and Radiopharmaceutic Industry
2.2 Nuclear Medicine and Radiopharmaceutic Market Trends
2.2.1 Nuclear Medicine and Radiopharmaceutic Production & Consumption Trends
2.2.2 Nuclear Medicine and Radiopharmaceutic Demand Structure Trends
2.3 Nuclear Medicine and Radiopharmaceutic Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Diagnostic Radioisotopes
4.2.2 Therapeutic Radioisotopes
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Oncology
4.3.2 Cardiology
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Diagnostic Radioisotopes
5.2.2 Therapeutic Radioisotopes
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Oncology
5.3.2 Cardiology
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Diagnostic Radioisotopes
6.2.2 Therapeutic Radioisotopes
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Oncology
6.3.2 Cardiology
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Diagnostic Radioisotopes
7.2.2 Therapeutic Radioisotopes
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Oncology
7.3.2 Cardiology
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Diagnostic Radioisotopes
8.2.2 Therapeutic Radioisotopes
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Oncology
8.3.2 Cardiology
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Diagnostic Radioisotopes
9.2.2 Therapeutic Radioisotopes
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Oncology
9.3.2 Cardiology
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Company
10.1.2 Bracco Imaging
10.1.3 Bayer
10.1.4 Mallinckrodt
10.1.5 Nordion
10.1.6 Triad Isotopes
10.1.7 Lantheus
10.1.8 IBA Group
10.1.9 GE Healthcare
10.1.10 China Isotope & Radiation
10.1.11 Jubilant Pharma
10.1.12 Eli Lilly
10.1.13 Advanced Accelerator Applications
10.1.14 SIEMENS
10.1.15 Dongcheng
10.1.16 Navidea
10.2 Nuclear Medicine and Radiopharmaceutic Sales Date of Major Players (2017-2020e)
10.2.1 Company
10.2.2 Bracco Imaging
10.2.3 Bayer
10.2.4 Mallinckrodt
10.2.5 Nordion
10.2.6 Triad Isotopes
10.2.7 Lantheus
10.2.8 IBA Group
10.2.9 GE Healthcare
10.2.10 China Isotope & Radiation
10.2.11 Jubilant Pharma
10.2.12 Eli Lilly
10.2.13 Advanced Accelerator Applications
10.2.14 SIEMENS
10.2.15 Dongcheng
10.2.16 Navidea
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
Table Nuclear Medicine and Radiopharmaceutic Product Type Overview
Table Nuclear Medicine and Radiopharmaceutic Product Type Market Share List
Table Nuclear Medicine and Radiopharmaceutic Product Type of Major Players
Table Brief Introduction of Company
Table Brief Introduction of Bracco Imaging
Table Brief Introduction of Bayer
Table Brief Introduction of Mallinckrodt
Table Brief Introduction of Nordion
Table Brief Introduction of Triad Isotopes
Table Brief Introduction of Lantheus
Table Brief Introduction of IBA Group
Table Brief Introduction of GE Healthcare
Table Brief Introduction of China Isotope & Radiation
Table Brief Introduction of Jubilant Pharma
Table Brief Introduction of Eli Lilly
Table Brief Introduction of Advanced Accelerator Applications
Table Brief Introduction of SIEMENS
Table Brief Introduction of Dongcheng
Table Brief Introduction of Navidea
Table Products & Services of Company
Table Products & Services of Bracco Imaging
Table Products & Services of Bayer
Table Products & Services of Mallinckrodt
Table Products & Services of Nordion
Table Products & Services of Triad Isotopes
Table Products & Services of Lantheus
Table Products & Services of IBA Group
Table Products & Services of GE Healthcare
Table Products & Services of China Isotope & Radiation
Table Products & Services of Jubilant Pharma
Table Products & Services of Eli Lilly
Table Products & Services of Advanced Accelerator Applications
Table Products & Services of SIEMENS
Table Products & Services of Dongcheng
Table Products & Services of Navidea
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Nuclear Medicine and Radiopharmaceutic Market Forecast (Million USD) by Region 2021f-2026f
Table Global Nuclear Medicine and Radiopharmaceutic Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Nuclear Medicine and Radiopharmaceutic Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Nuclear Medicine and Radiopharmaceutic Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
